B+
Bull case
20%
Probability
Target price
$8.00
Analysis reference price unavailable
Analysis 2025-12-06 · RankAlpha Sentiment AI
TSHA
Taysha Gene TherapiesCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
Positive clinical readouts or a partnership deal that materially extends runway would validate Taysha's CNS program value and could drive a strong rerating toward the bull target; modest near-term dilution risk would be offset by de-risking milestones.
Posture
Mixed
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta +10.5.
What can break
Failure to secure financing before mid-2026 or disappointing clinical data would likely cause a deep drawdown toward the bear target; limited near-term revenue and binary program outcomes amplify downside.
Momentum
18
Value
41
Sentiment
64
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $5.50 · Bull $8.00 · Bear $3.00Analysis 2025-12-06; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-09 • Model: HYBRID_IC_RP
AI Memo
As of 2025-12-06 • Model: RankAlpha Sentiment AI
Investment thesisAs of 2026-09-09
Investment thesis
As of 2026-09-09
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-09. Definitions
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $13.33
Why
Momentum18 · Δ7d -3.1
Value41 · Δ7d 0.0
Sentiment64 · Δ7d +10.5
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Confirming evidence
- • Sentiment remains the lead driver in the composite, 7D delta +10.5.
Contradictions & invalidation
- • Failure to secure financing before mid-2026 or disappointing clinical data would likely cause a deep drawdown toward the bear target; limited near-term revenue and binary program outcomes amplify downside.
- • Mixed signals. Wait for cleaner trend confirmation.
Catalyst clock
No dated catalyst is available.
Clinical data readouts from CNS programs
Lead driver: Sentiment · See AI snapshot
Momentum
18
9% active weight
Current posture
7d trendSoftening
Δ7d
-3.1
Δ21d
-51.7
Value
41
28% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
+0.1
Sentiment
64
62% active weight
Current posture
7d trendImproving
Δ7d
+10.5
Δ21d
+16.5
Why this grade
Composite grade C. Momentum 17.7 / Value 41.2 / Sentiment 64.4
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2025-12-06. Scenario method
Most likely
B
Base case
55%
Probability
Target price
$5.50
Analysis reference price unavailable
Analysis 2025-12-06 · RankAlpha Sentiment AI
B-
Bear case
25%
Probability
Target price
$3.00
Analysis reference price unavailable
Analysis 2025-12-06 · RankAlpha Sentiment AI
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$2.02B
Beta
0.99
Shares Out
325.83M
P/E (TTM) · Derived
-18.2
P/S (TTM)
212.28
P/FCF (TTM) · Derived
-16.16
Rev YoY
-100.0%
EPS YoY
+40.1%
Gross Margin
+78.7%
Op Margin
-1618.5%
Net Debt
-$249.69M
Current Ratio
17.76
As of 2026-09-09 • Updated nightlySource: Internal modelMethods & Data